4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
InterCure Ltd. (INCR) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Herzliya, Israel with about 285 employees. Its market capitalization is roughly $81 million. In the fiscal year ended 2025-12-31, INCR reported ₪270M in revenue and (₪36M) in net income.
InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | ₪270M | ₪239M | ₪356M | ₪389M | — |
| Gross Profit | ₪33M | ₪30M | ₪105M | ₪155M | — |
| Operating Income (EBIT) | ₪7M | (₪45M) | ₪38M | ₪41M | — |
| Net Income | (₪36M) | (₪68M) | (₪62M) | ₪45M | — |
ILS; ₪M / ₪B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | ₪0M | ₪0M | ₪0M | ₪0M | — |
ILS; ₪M / ₪B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | ₪691M | ₪763M | ₪787M | ₪958M | — |
| Total Liabilities | ₪294M | ₪365M | ₪330M | ₪436M | — |
ILS; ₪M / ₪B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive INCR viewer.
About TickerBase · Data methodology & sources · Privacy · Terms